18 - 20 October, 2010, Andel’s Hotel, Berlin, Germany
Register by 30th July 2010 and receive up to €450 off!
Download the Brochure
Click here to access Download Centre
Become a Pharma IQ Member and receive our weekly newsletter!
Learn more about sponsor & exhibit opportunities
Countdown to Event
Mark Your Calendar
Tell a Colleague
With the recent amendments to the Medical Device Directive (2007/47/EC), it is essential that you adapt your evaluations and investigations strategy to maintain complete compliance. However, it is also key that this change in directive does not impact on the bottom line of your company.
Pharma IQ’s Clinical Evaluations and Investigations for Medical Devices Conference will bring together regulators, notified bodies, medical device professionals and CRO’s all tasked with the same remit; medical device evaluations and trials.
This conference will offer attendees the opportunity to discuss the key challenges currently being faced as well as possible solutions and also gain immediate clarification over the new guidelines from the regulatory bodies represented.
Dr Dirk Wetzel Head of Division, Medical Devices BfArM, Germany
Robert Higgins Medical Device Regulations MHRA, UK
Dr Gert Bos Head of Clinical, and Regulatory Affairs BSI Healthcare
Martin de Bruin Director Medical Businessline KEMA Quality/DEKRA Notified Body
Stefan Menzl Director Regulatory Affairs, Compliance Europe, Africa,Middle East Abbott Medical Optics, Germany
Ian Quirk Worldwide Director, Clinical and Regulatory Affairs Ranier Technology Limited
» Click here for full speaker list
Gain critical regulatory updates on the change to the MDD (2007/47/EC), how other companies have risen to this new challenge and how you can do the same: Abbott Medical Optics share their experiences from recent CE qualifications
Ensure complete regulatory compliance and operational effectiveness through assessing best practice approaches in designing your clinical investigation: ev3 and Boston Scientific share their recent experience
Make sure your project is progressing on time and on budget when outsourcing by establishing key performance metrics and parameters to maintain control: Orbusneich Medical discuss the most effective methods and how you can implement them
Keep your product on the market by ensuring effective, compliant post market surveillance with guidance from Ranier Technology Ltd. and Cryolife Europa Ltd.
Achieve market access by executing thorough clinical literature reviews and establish best practice: Siemens AG share their experience
[ Register Now ]